This is a preview of subscription content, log in via an institution to check access.
Reference
Broadbent DM, et al. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT. Diabetologia : 4 Nov 2020. Available from: URL: http://doi.org/10.1007/s00125-020-05313-2
Rights and permissions
About this article
Cite this article
Individualised screening for diabetic retinopathy cost saving. PharmacoEcon Outcomes News 867, 21 (2020). https://doi.org/10.1007/s40274-020-7318-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7318-z